Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Receivables (2023 - 2025)

Historic Receivables for Connect Biopharma Holdings (CNTB) over the last 3 years, with Q3 2025 value amounting to $174000.0.

  • Connect Biopharma Holdings' Receivables changed N/A to $174000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $174000.0, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2024, which is 19943.02% up from last year.
  • According to the latest figures from Q3 2025, Connect Biopharma Holdings' Receivables is $174000.0.
  • In the past 5 years, Connect Biopharma Holdings' Receivables ranged from a high of $1.1 million in Q4 2024 and a low of $174000.0 during Q3 2025
  • In the last 3 years, Connect Biopharma Holdings' Receivables had a median value of $193000.0 in 2025 and averaged $388800.0.
  • The largest annual percentage gain for Connect Biopharma Holdings' Receivables in the last 5 years was 19943.02% (2024), contrasted with its biggest fall of 19943.02% (2024).
  • Connect Biopharma Holdings' Receivables (Quarter) stood at $351000.0 in 2023, then surged by 199.43% to $1.1 million in 2024, then crashed by 83.44% to $174000.0 in 2025.
  • Its last three reported values are $174000.0 in Q3 2025, $193000.0 for Q2 2025, and $175000.0 during Q1 2025.